MARY HOCHKINS: Open Payments
NPI 1720472087 · JASPER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,799 in 79 payments from 14 companies in 2025. Trend: 2023 $1,501 · 2024 $1,288 · 2025 $1,799
Food & beverage: $1,799
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $323 |
| Janssen Biotech, Inc. | 10 | $260 |
| Madrigal Pharmaceuticals | 13 | $258 |
| ABBVIE INC. | 12 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $163 |
| GENZYME CORPORATION | 8 | $159 |
| QOL Medical, LLC | 4 | $137 |
| Lilly USA, LLC | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| PFIZER INC. | 3 | $55 |
Products named: DUPIXENT, TREMFYA, REZDIFFRA, Sucraid, ENTYVIO, OMVOH, XIFAXAN, CREON.
Industry payments across GA — which companies pay providers there.
